MUTLU AĞARDAN, N. B. Et Al. 2011. New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7 , 775-789.

MUTLU AĞARDAN, N. B., Degim, Z., Yilmaz, S., EŞSİZ, D., & NACAR, A., (2011). New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7, 775-789.

MUTLU AĞARDAN, NECİBE Et Al. "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7, 775-789, 2011

MUTLU AĞARDAN, NECİBE B. Et Al. "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7, pp.775-789, 2011

MUTLU AĞARDAN, N. B. Et Al. (2011) . "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.7, pp.775-789.

@article{article, author={NECİBE BAŞARAN MUTLU AĞARDAN Et Al. }, title={New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2011, pages={775-789} }